Danny Hsu: The Diagnostic Challenge of Pulmonary Embolism During Pregnancy
Danny Hsu, President of THANZ, shared RPTH Journal’s post on LinkedIn, adding:
“Excellent article on the challenging scenario of diagnosing PE in pregnancy!”
RPTH Journal shared a post on LinkedIn, about a recent article by Fanny Collange et al, adding: :
“Diagnosing pulmonary embolism in pregnancy is still harder than we think.
We rely heavily on clinical probability scores like Wells and Geneva, but do they actually work in pregnant women with prior VTE?
A new Highlow ancillary study puts this to the test in 1,110 high-risk pregnancies.
The results are eye-opening
Among 102 suspected PE cases:
- Only 12 were confirmed
- Incidence during pregnancy: 2.6% of suspected cases
- Postpartum: 42% of suspected cases
Now the key finding:
Wells, Geneva, and pregnancy-adapted Geneva scores all showed modest discriminatory power
Translation:
These tools struggle in the exact population where we need them most.
Why?
Because pregnancy changes physiology, symptoms overlap with normal pregnancy, and prior VTE history dominates risk assessment.
Big takeaway:
We urgently need pregnancy-specific PE decision tools to safely reduce imaging and radiation exposure.
This study highlights a major unmet need in maternal thrombosis care.”
Title: Assessment of clinical probability scores for pulmonary embolism diagnosis during pregnancy and postpartum in women with a history of venous thromboembolism: a Highlow ancillary study
Authors: Fanny Collange, Ingrid M Bistervels, Andrea Buchmuller, Hanke MG Wiegers, Fionnuala Ní Áinle, Peter Verhamme, Anne F Jacobsen, Anette T Hansen, Marc A Rodger, Maria T DeSancho, Roman G Shmakov, Luuk JJ Scheres, Celine Chauleur, Saskia Middeldorp, Bernard Tardy
Read the Full Article on RPTH Journal.
Find more posts featuring Danny Hsu on Hemostasis Today.
-
Sep 30, 2026, 15:58Bernhard Merget: New Frontiers in Thrombosis and Stroke Research
-
Sep 30, 2026, 15:39Ifeanyichukwu Ifechidere: The Molecular Orchestra of Primary Hemostasis
-
Sep 30, 2026, 15:28Reassessing the Benefit–Risk Balance of Extended Anticoagulation in Cancer Patients – ESC Working Group on Cardiovascular Pharmacotherapy
-
Sep 30, 2026, 15:07Chiranjeev Sharma: Targeting Factor XIa with the Synthetic Inhibitor SB-01
-
Sep 30, 2026, 14:41Bruna Gigante: Balancing Thrombosis and Bleeding in Cardiovascular Care
-
Sep 30, 2026, 14:13Ashok Choudhury: Portal Vein Thrombosis and Outcomes in Cirrhosis
-
Sep 30, 2026, 13:57Leslye Conde Bazán: When Conventional Imaging Is Not Enough – The Role of IVUS
-
Sep 30, 2026, 13:41Huda Salah Eldin: The Challenge of Balancing Antithrombotic Therapy After PCI
-
Sep 30, 2026, 13:29Abdus Salam: What Can CT Venography Reveal About the Veins?